Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
The ground state of embryonic stem cell self-renewal
PD158780 shows good therapeutic effect against the A431 epidermoid carcinoma when administered either intraperitoneally or orally
is a potent Rho-kinase inhibitor and vasodilator
2ClH/c17-19(18
BAY-2416964 - CAS# 2242464-44-2 Catalog No.:M7082-2 The ground state of embryonicBAY 2416964, CAS No. 2242464 44 2, is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 192, has an IC50 of 341 nM. BAY2416964 specifically binds to AhR, inhibits AhR activation, and prevents AhR mediated signaling. Abrogation of AhR activation prevents the activation of immune tolerant dendritic cells (DCs) and regulatory T cells (Tregs) in the tumor microenvironment (TME). This may
US$ 94.00
US$ 49.99
US$ 49.99
US$ 19.99
US$ 155.00
US$ 2250.00
US$ 74.99